New drug combo tested for tough childhood cancers
NCT ID NCT01946529
Summary
This study is testing a combination of chemotherapy drugs for young patients (up to age 25) with high-risk Ewing sarcoma or desmoplastic small round cell tumors. Participants are divided into two groups: one receives standard treatment, and the other receives a more intensive regimen that includes newer drugs. The goal is to see if the new drug combination can better control these difficult cancers and improve survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DESMOPLASTIC SMALL ROUND CELL TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
St. Jude Children's Research Hospital
Memphis, Tennessee, 38105, United States
Conditions
Explore the condition pages connected to this study.